• Fosamax
• Fosamax Bone Fractures
• Fosamax Bone Loss
• Fosamax Dead Jaw
• Fosamax Jaw Bone Loss
• Fosamax Femur Fractures
• Fosamax Lawsuit
• Fosamax Lawyers
• Fosamax Attorneys
• Fosamax Dead Jaw Lawsuit
• Fosamax Dead Jaw Lawyers
• Fosamax Osteonecrosis
• Fosamax Side Effects
• Fosamax Warning
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Fosamax® (alendronate) is a bisphosphonate drug, a class of medications to treat and prevent thinning of the bones or osteoporosis. Postmenopausal women, who are at highest risk for osteoporosis, are the largest group of patients taking the medication, but premenopausal women and some men also take Fosamax®.

Fosamax® is also used to treat some patients who are taking corticosteroids, medications that may lead to bone thinning, and patients with Paget’s disease, an illness causing the bones to become soft, weak, or deformed, painful and easily broken. It also is given to certain patients with bone cancer.

Fosamax® and Osteonecrosis of the Jaw

A link has been found between taking Fosamax® and the condition known as dead jaw or osteonecrosis of the jaw (ONJ). Persons whose risk is highest have

• Taken intravenous formulations of Fosamax®
• Taken steroids at the same time they’re taking Fosamax®
• A history of metastatic disease to the bone
• Osteoporosis
• Paget’s disease
• A history of invasive dental procedures such as tooth extraction, tooth implantation or other oral surgeries

Symptoms of osteonecrosis of the jaw include

• Loosening of the teeth
• Soft tissue swelling and inflammation
• Pain
• Infection of jaw tissue
• Drainage

Financial Recoveries For Fosamax® Patients

Eight million dollars was awarded to a Walton Beach, Florida, women, in the first lawsuit to successfully recover damages for taking Fosamax® and subsequently suffering ONJ. The award was decided at the end of June 2010 by a federal court jury in New York City.

The patient had used Fosamax® from 1997 to 2006 and eventually suffered from dead jaw. Merck & Co., the manufacturer of Fosamax®, said in a press release that the award was unjustified and excessive.

Merck, reportedly, is expected to file post-trial motions in September to overturn the verdict and will probably appeal the decision if the motions are not successful. Merck plans to have the $8 million verdict reduced or dismissed it said in a press release issued the same day as the verdict came down.

Merck said the women’s history of long-time smoking and severe periodontal disease predated her use of Fosamax®. Information about the lawsuits given by Merck said about 1,039 cases, which included 1,417 plaintiff groups, had been filed and were pending against the company in either federal or state court.

Ask a Lawyer About Your Injury

If you have taken Fosamax® and then suffered from ONJ, or another complication, you should contact a Fosamax® dead jaw lawyer, someone who specializes in helping these patients win favorable verdicts. You deserve to be fully compensated for the pain, suffering and expense you have endured because of ONJ. To find out if you qualify, contact our Fosamax® attorneys today.

"Women Twice as Likely to Develope Atrial Fibrillation"

A new study suggests that women taking the osteoporosis drug Fosamax are twice as likely to develop a chronic heart condition known as atrial fibrillat...

» Read More

"Conn. Woman suffers from stress fractures and suppressed bone regeneration"

A new lawsuit has been filed against Merck & Co. over its osteoporosis drug Fosamax. The suit claims the drug caused a Connecticut woman to suffer multiple stress fractures in her l...

» Read More

"Fosamax Lawsuit Cites Merck’s Negligence"

A lawsuit filed in a Florida federal court is claiming that Merck, the maker of Fosamax, was negligent in promoting its popular osteoporosis drug.

According to the complaint, Merck knew that Fosamax was defective but continuously concealed i...

» Read More